ERCC5 and non-small cell lung carcinoma: Based on presented data, obtained in appropriately sized populations, we can conclude that the effect of the ERCC5 polymorphism in the 5′ untraslated region has no effects on response to therapy of NSCLC and EOC Caucasian patients.